T
The Retina Clinic London | London, United Kingdom
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
JNJ-81201887
GT005
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.
Active, not recruiting
Geographic Atrophy
Drug: Triamcinolone
Other: Sham Procedure
The purpose of this study is to evaluate the long-term safety of GT005 in participants with Geographic Atrophy (GA) secondary to AMD who have been tr...
Invitation-only
Age Related Macular Degeneration (AMD)
Genetic: GT005
ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular d...
Enrolling
Wet Age-related Macular Degeneration
WetAMD
Biological: Aflibercept (EYLEA®)
Genetic: ABBV-RGX-314 Dose 2
Trial sponsors
G
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems